News

Aug 04 2017

Auris Health, formerly known as Auris Surgical Robotics, is featured in this article for its significant achievement in financing along with details surrounding its technology. Under the leadership of serial entrepreneur and Auris CEO, Dr. Fred Moll, Auris raised $280 million in a Series D round of financing. This was a generous amount to add to the existing $149.5 million from its Series C financing.

Aug 04 2017

Auris is featured in this TechCrunch article not only for its impressive Series D funding but also for the opportunity it brings with its focus on the lung cancer market. Lung cancer claims more victims than prostate, breast, and colon cancer combined. It remains a very dangerous form of cancer because a diagnosis often comes late, when the cancer has already spread.

Aug 03 2017

Auris Health’s $280 million Series D financing made headlines in the Wall Street Journal. According to the article, the company’s financing is part of a significant increase in medical-technology venture funding. It also spoke of Auris CEO Dr. Fred Moll, a robotic-surgery pioneer and serial entrepreneur with much success from previous companies he founded.

Jul 17 2017

Auris joined the unicorn ranks in 2017 for reaching billion-dollar valuation. According to the article, 53 venture capital-backed companies reached billion-dollar valuations last year. Auris is the only company listed for robotics, medical robotics or endoscopy robotics.

Jan 23 2017

Even when Auris Health, Inc., formerly known as Auris Surgical Robotics, was in stealth mode, it was recognized as a fierce company, thanks to the innovation and experience of Auris CEO, Dr. Fred Moll. The serial entrepreneur and innovator has long contributed to the robotics space.

Jan 06 2017

Recent data showed the rise in robotics funding across various categories. According to the article, robotic startups had a record year in 2016 globally. Despite the majority of growth coming from the enterprise and consumer categories, the medical category saw an increase too. According to the article, Auris Health, Inc., formerly known as Auris Surgical Robotics, had the most funding for its robotic technology.

Aug 30 2016

This article featured Auris Health, formerly known as Auris Surgical Robotics, for how well-funded it is by venture capitalists. According to the article, one of Auris’s major investors, Lux Capital, made the list for most active VC investors in robotics from 2011 – 2016. Additionally, Auris ranked at the top for being the most-well funded robotics company from 2011 – 2016.

Jul 31 2016

Stealthy Auris Health, Inc., formerly known as Auris Surgical Robotics, made the list of 10 robotic surgery companies to be watched. According to the article, robotic technology may be a less invasive approach with higher success rates, in comparison to today’s more traditional approaches. Auris was specifically mentioned for its impressive funding and 2016 FDA clearance for its robotic endoscopy system, ARES (Auris Robotic Endoscopy System).

Jul 28 2016

Silicon Valley-based Auris Health, made headlines for the FDA clearance of its robotic endoscopy system ARES (Auris Robotic Endoscopy System). According to the article, the technology could assist physicians with both visualizing and treating several lung conditions. Auris’s advanced bronchoscopic system could also make the procedure easier to perform for physicians, according to the article. Auris’s robotic approach could allow for less fatigue on the medical professional, unlike traditional bronchoscopy procedures.

Jun 07 2016

Auris Health, Inc., formerly known as Auris Surgical Robotics, is featured in this article for its FDA-cleared ARES, Auris Robotic Endoscopy System, and the curiosity it brings to what the company could plan to do with its technology.